| Literature DB >> 22870302 |
Walter L Siqueira1, Meltem Bakkal, Yizhi Xiao, Jennifer N Sutton, Fausto M Mendes.
Abstract
The acquired enamel pellicle (AEP) is a thin film formed by the selective adsorption of salivary proteins onto the enamel surface of teeth. The AEP forms a critical interface between the mineral phase of teeth (hydroxyapatite) and the oral microbial biofilm. This biofilm is the key feature responsible for the development of dental caries. Fluoride on enamel surface is well known to reduce caries by reducing the solubility of enamel to acid. Information on the effects of fluoride on AEP formation is limited. This study aimed to investigate the effects of fluoride treatment on hydroxyapatite on the subsequent formation of AEP. In addition, this study pioneered the use of label-free quantitative proteomics to better understand the composition of AEP proteins. Hydroxyapatite discs were randomly divided in 4 groups (n = 10 per group). Each disc was exposed to distilled water (control) or sodium fluoride solution (1, 2 or 5%) for 2 hours. Discs were then washed and immersed in human saliva for an additional 2 hours. AEP from each disc was collected and subjected to liquid chromatography electrospray ionization mass spectrometry for protein identification, characterization and quantification. A total of 45 proteins were present in all four groups, 12 proteins were exclusively present in the control group and another 19 proteins were only present in the discs treated with 5% sodium fluoride. Relative proteomic quantification was carried out for the 45 proteins observed in all four groups. Notably, the concentration of important salivary proteins, such as statherin and histatin 1, decrease with increasing levels of fluoride. It suggests that these proteins are repulsed when hydroxyapatite surface is coated with fluoride. Our data demonstrated that treatment of hydroxyapatite with fluoride (at high concentration) qualitatively and quantitatively modulates AEP formation, effects which in turn will likely impact the formation of oral biofilms.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22870302 PMCID: PMC3411614 DOI: 10.1371/journal.pone.0042204
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1XPS wide scan spectrum of HA surface disc
(A) and HA surface disc pre-treated with 1 % NaF (B), 2% NaF (C) and 5% NaF (D). Note: arrow indicates the fluoride peak at 685 eV binding energy.
Figure 2Examples of base-peak chromatograms of each studied group.
Peptide separation was achieved using a nano-flow reverse-phase HPLC column, with gradient elution ranging from 5 to 55% solvent B in 65 min.
Salivary proteins identified on hydroxyapatite discs and hydroxyapatite discs treated with 1%, 2% and 5% NaF.
| Acession number | Protein name | |
|
| B1AN48 | Small proline-rich protein 3 |
| P01036 | Cystatin-S | |
| P01037 | Cystatin-SN | |
| P01620 | Ig kappa chain V-III region SIE | |
| P01777 | Ig heavy chain V-III region TEI | |
| P01781 | Ig heavy chain V-III region GAL | |
| P01833 | Polymeric immunoglobulin receptor | |
| P01834 | Ig kappa chain C region | |
| P01857 | Ig gamma-1 chain C region | |
| P01871 | Ig mu chain C region | |
| P01876 | Ig alpha-1 chain C region | |
| P01877 | Ig alpha-2 chain C region | |
| P02808 | Statherin | |
| P02812 | Basic salivary proline-rich protein 2 | |
| P02814 | Submaxillary gland androgen-regulated protein 3B | |
| P04075 | Fructose-bisphosphate aldolase A | |
| P04080 | Cystatin-B | |
| P04264 | Keratin, type II | |
| P04745 | Alpha-amylase 1 | |
| P05109 | Protein S100-A8 | |
| P06702 | Protein S100-A9 | |
| P06733 | Alpha-enolase | |
| P09211 | Glutathione S-transferase | |
| P09228 | Cystatin-SA | |
| P0CG05 | Ig lambda-2 chain C regions | |
| P11021 | 78 kDa glucose-regulated protein | |
| P12273 | Prolactin-inducible protein | |
| P13645 | Keratin, type I | |
| P15515 | Histatin-1 | |
| P23284 | Peptidyl-prolyl cis-trans isomerase B | |
| P25311 | Zinc-alpha-2-glycoprotein | |
| P29508 | Serpin B3 | |
| P30740 | Leukocyte elastase inhibitor | |
| P31025 | Lipocalin-1 | |
| P35527 | Keratin, type I cytoskeletal 9 | |
| P54108 | Cysteine-rich secretory protein 3 | |
| P61626 | Lysozyme C | |
| Q96DA0 | Zymogen granule protein 16 | |
| B7Z4X2 | Lactotransferrin | |
| E7EMJ3 | Lactoperoxidase | |
| E7EMQ1 | Carbonic anhydrase VI | |
| E7EQ46 | Uncharacterized protein | |
| P02768 | Albumin | |
| E9PBV3 | Suprabasin | |
| F5GXH2 | Lactate dehydrogenase A | |
|
| B1AHN5 | Hsp70 interacting protein |
| P01009 | Serpin A1 | |
| P01605 | Ig kappa chain V-I region | |
| P02810 | Salivary acidic proline-rich phosphoprotein 1 | |
| P27482 | Calmodulin 3 | |
| Q8IUK7 | ALB protein | |
| F5GYT4 | Actin, beta | |
| F5H0L3 | 6-phosphogluconate dehydrogenase | |
|
| B4DRT4 | Phosphatidylethanolamine-binding protein 1 |
| P02533 | Cytokeratin-14 | |
| P0CG04 | Ig lambda-1 chain C regions | |
| P13647 | Keratin, type II cytoskeletal 5 | |
| P35908 | Keratin, type II cytoskeletal 2 | |
|
| B1ALW1 | Thioredoxin |
| Q08188 | Protein-glutamine gamma-glutamyltransferase | |
| Q8TDL5 | Long palate, lung and nasal epithelium carcinoma-associated protein 1 | |
| E9PKG6 | Nucleobindin 2 | |
|
| E7EUT5 | Glyceraldehyde-3-phosphate dehydrogenase |
| P01034 | Cystatin-C | |
| P02787 | Serotransferrin | |
| P08493 | Matrix Gla protein | |
| P27797 | Calreticulin | |
| P81605 | Preproteolysin | |
| Q13765 | NAC-alpha | |
| Q6P5S2 | protein C6orf58 | |
| P37802 | transgelin-2 | |
|
| P08779 | Keratin, type I cytoskeletal 16 |
|
| P01625 | Ig kappa chain V-IV region Len |
| Q86YZ3 | Hornerin | |
| Q8IWZ5 | Tripartite motif-containing protein 42 | |
|
| O00391 | Sulfhydryl oxidase 1 |
| P01597 | Ig kappa chain V-I region | |
| P15924 | Desmoplakin | |
| P31949 | Protein S100-A11 | |
| P62158 | Calmodulin | |
| Q02413 | Desmoglein-1 | |
| Q16739 | Ceramide glucosyltransferase | |
| Q6ZVX7 | Non-specific cytotoxic cell receptor protein 1 homolog | |
| Q8TDN4 | Ik3-1 | |
| C9J0E4 | Cystatin A (stefin A) | |
| E5RGE1 | zeta polypeptide | |
| E9PHI2 | Heat shock protein 90 kDa alpha | |
|
| P01040 | Cystatin-A |
| Q9HC84 | Mucin-5B | |
| F5GZ39 | Ubiquitin C | |
| F5H805 | Uncharacterized protein | |
|
| P07108 | Acyl-CoA-binding protein |
| Q01469 | Fatty acid-binding protein | |
|
| Q96DR5 | Short palate, lung and nasal epithelium carcinoma-associated protein 2 |
| E7EPA8 | Prolyl 4-hydroxylase, beta polypeptide | |
|
| P20930 | Filaggrin |
| D6R9A6 | High mobility group protein B2 | |
| E9PLJ3 | Cofilin 1 | |
|
| P01593 | Ig kappa chain V-I region AG |
| P01617 | Ig kappa chain V-II region TEW | |
| P01765 | Ig heavy chain V-III region TIL | |
| P18510 | Interleukin-1 receptor antagonist protein | |
| E7EQR4 | Ezrin | |
|
| B4E1H9 | Phosphoglycerate kinase |
| P16401 | histone H1.5 | |
| P80748 | Ig lambda chain V-III region | |
| Q567Q0 | Cyclophilin A | |
| E7EPW1 | Uncharacterized protein | |
| B4DUA5 | Uncharacterized protein | |
|
| E9PF79 | Pyruvate kinase |
| P00558 | Phosphoglycerate kinase 1 | |
| P04083 | Annexin A1 | |
| P04406 | Glyceraldehyde-3-phosphate dehydrogenase | |
| P05164 | Myeloperoxidase | |
| P07737 | Profilin-1 | |
| P17931 | Galectin-3 | |
| P23528 | Cofilin-1 | |
| P26038 | Moesin | |
| P30040 | Endoplasmic reticulum resident protein 29 | |
| P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | |
| Q5SX91 | GDP dissociation inhibitor 2 (Fragment) | |
| Q5T8F0 | Cathepsin L1 | |
| C9J8F3 | Uncharacterized protein | |
| C9JMC5 | Uncharacterized protein | |
| E7EQL7 | Uncharacterized protein | |
| E9PFF2 | Transketolase | |
| F5H0N0 | Actin, gamma 1 | |
| F5H8B6 | Proteinase 3 |
Figure 3Venn diagram of AEP proteins identified in each group and across groups.
AEP protein abundance ratios from 1% NaF, 2% NaF and 5% NaF groups.
| Accession Number | Protein Name | Ratio 1%NaF/HA | p | Ratio 2%NaF/HA | p | Ratio 5%NaF/HA | p |
| P01620 | Ig kappa chain V-III region SIE | 1.11 | 0.605 | 1.09 | 0.001 | 0.83 | 0.154 |
| B1AN48 | Small proline-rich protein 3 | 1.06 | 0.326 | 0.81 | 0.001 | 0.77 | 0.001 |
| B7Z4X2 | highly similar to Lactotransferrin | 0.79 | 0.001 | 0.84 | 0.001 | 0.88 | 0.001 |
| E7EMJ3 | Lactoperoxidase | 0.88 | 0.514 | 0.38 | 0.001 | 0.02 | 0.001 |
| E7EMQ1 | Carbonic anhydrase 6 | 0.77 | 0.240 | 0.76 | 0.064 | 0.63 | 0.014 |
| E7EQ46 | Uncharacterized protein | 0.93 | 0.989 | 0.89 | 0.006 | 1.02 | 0.374 |
| P02768 | Serum albumin | 0.85 | 0.132 | 0.67 | 0.001 | 0.62 | 0.001 |
| E9PBV3 | Suprabasin | 1.15 | 0.239 | 1.22 | 0.191 | 0.94 | 0.093 |
| F5GXH2 | Lactate dehydrogenase A | 0.85 | 0.269 | 0.94 | 0.004 | 0.86 | 0.001 |
| P01036 | Cystatin S | 0.90 | 0.001 | 0.65 | 0.001 | 0.73 | 0.001 |
| P01037 | Cystatin SN | 0.77 | 0.001 | 0.62 | 0.001 | 0.56 | 0.001 |
| P01777 | Ig heavy chain VIII region TEI | 0.89 | 0.847 | 0.82 | 0.006 | 0.71 | 0.001 |
| P01781 | Ig heavy chain VIII region GAL | 1.01 | 0.968 | 0.94 | 0.896 | 1.09 | 0.966 |
| P01833 | Polymeric immunoglobulin receptor | 0.96 | 0.366 | 0.95 | 0.245 | 1.04 | 0.118 |
| P01834 | Ig kappa chain C region | 0.85 | 0.001 | 0.88 | 0.001 | 0.78 | 0.001 |
| P01857 | Ig gamma 1 chain C region | 0.94 | 0.256 | 0.81 | 0.068 | 0.78 | 0.001 |
| P01871 | Ig mu chain C region | 1.11 | 0.496 | 0.96 | 0.992 | 1.14 | 0.719 |
| P01876 | Ig alpha 1 chain C region | 1.01 | 1.000 | 0.96 | 0.037 | 1.04 | 0.352 |
| P01877 | Ig alpha 2 chain C region | 1.00 | 0.279 | 0.84 | 0.058 | 0.83 | 0.001 |
| P02808 | Statherin | 0.86 | 0.999 | 0.44 | 0.001 | 0.38 | 0.001 |
| P02812 | Basic salivary proline rich protein 2 | 1.12 | 0.008 | 1.35 | 0.001 | 1.88 | 0.004 |
| P02814 | Proline-rich protein 3 | 0.76 | 0.001 | 0.83 | 0.013 | 0.72 | 0.001 |
| P04075 | Fructose bisphosphate aldolase A | 1.05 | 0.528 | 0.91 | 0.173 | 0.95 | 0.317 |
| P04080 | Cystatin B | 0.90 | 0.510 | 0.88 | 0.329 | 0.72 | 0.001 |
| P04264 | Keratin type II cytoskeletal 1 | 0.54 | 0.001 | 0.60 | 0.001 | 0.72 | 0.001 |
| P04745 | Alpha amylase 1 | 0.95 | 0.935 | 0.60 | 0.049 | 0.72 | 0.004 |
| P05109 | Protein S100A8 | 1.07 | 0.163 | 0.94 | 0.001 | 1.25 | 0.001 |
| P06702 | Protein S100A9 | 1.16 | 0.001 | 1.03 | 0.001 | 1.04 | 0.001 |
| P06733 | Alpha enolase | 0.75 | 0.001 | 0.62 | 0.001 | 0.49 | 0.001 |
| P09211 | Glutathione S transferase P | 0.85 | 0.586 | 0.76 | 0.039 | 0.81 | 0.122 |
| P09228 | Cystatin SA | 1.09 | 0.002 | 0.93 | 0.010 | 0.69 | 0.001 |
| P0CG05 | Ig lambda-2 chain C regions | 0.92 | 0.001 | 0.83 | 0.935 | 0.96 | 0.222 |
| P11021 | 78 kDa glucose regulated protein | 1.01 | 0.570 | 0.88 | 0.380 | 0.96 | 0.078 |
| P12273 | Prolactin inducible protein | 0.86 | 0.986 | 0.86 | 0.933 | 0.89 | 0.461 |
| P13645 | Keratin_ type I cytoskeletal 10 | 0.66 | 0.000 | 0.61 | 0.001 | 0.60 | 0.001 |
| P15515 | Histatin 1 | 0.90 | 0.001 | 0.60 | 0.001 | 0.58 | 0.001 |
| P23284 | Peptidylprolyl cistrans isomerase B | 1.10 | 0.001 | 1.01 | 0.993 | 1.06 | 0.513 |
| P25311 | Zinc alpha 2 glycoprotein | 0.99 | 1.000 | 0.85 | 0.290 | 0.95 | 1.000 |
| P29508 | Serpin B3 | 0.94 | 0.422 | 0.87 | 0.187 | 1.01 | 0.632 |
| P30740 | Leukocyte elastase inhibitor | 0.96 | 0.905 | 0.79 | 0.001 | 1.02 | 0.141 |
| P31025 | Lipocalin 1 | 0.92 | 0.808 | 0.83 | 0.006 | 0.97 | 0.964 |
| P35527 | Keratin type I cytoskeletal 9 | 0.57 | 0.000 | 0.55 | 0.001 | 0.68 | 0.001 |
| P54108 | Cysteine rich secretory protein 3 | 1.00 | 0.013 | 0.69 | 0.001 | 0.65 | 0.001 |
| P61626 | Lysozyme C | 0.72 | 0.000 | 0.59 | 0.001 | 0.48 | 0.001 |
| Q96DA0 | Zymogen granule protein 16 homolog B | 0.79 | 0.250 | 0.70 | 0.002 | 0.52 | 0.002 |
Note. Ratio HA/HA was used as reference and the value for all proteins is 1.000. p: statistical p-value.
Figure 4ELISA experiment with 10 µg/ml of AEP material for each group and anti-statherin antibody.
Each bar represents the mean value ±SD of one experiment performed in triplicate.
Atoms % of Calcium, Fluoride and Phosphorus on the HA surface treated with NaF.
| Calcium | Fluoride | Phosphorus | Ratio Calcium/Phosphorus | ||
| HA | 16.8±0.4 | 9.8±0.7 | 1.71 | ||
| 1% NaF | 10.2±1.4 | 9.1±1.0 | 6.2±0.6 | 1.64 | |
| 2% NaF | 12.2±0.3 | 9.8±0.7 | 7.9±0.7 | 1.55 | |
| 5% NaF | 6.7±0.2 | 14.3±0.8 | 5.2±0.4 | 1.29 | |
Mean ±SD.
Figure 5Alignment results from 12 base-peak chromatograms (3 base-peak chromatograms per group) generated by SIEVE.
Inset: example of an extracted mass chromatogram for a peptide whose abundance is increased in HA (Blue), 1% NaF(red), 2% NaF (violet) groups and decreased in 5% NaF group (green).